Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A decrease in cell-mediated immunity in uremia associated with an increase in activity of suppressor cells

J Raskova, A B Morrison

    The American Journal of Pathology
    |July 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Aneroid sphygmomanometers.

    Canadian Medical Association journal·2010
    Same author

    Retinoic acid in acne therapy.

    Canadian Medical Association journal·2010
    Same author

    Precautionary labelling on preparations of retinoic acid.

    Canadian Medical Association journal·2010
    Same author

    The use of diathermy in the presence of metal implants and cardiac pacemakers.

    Canadian Medical Association journal·2010
    Same author

    Rate of Drug Release.

    Canadian Medical Association journal·2010
    Same author

    Trace Elements in Human Nutrition.

    Canadian Medical Association journal·2010
    Same journal

    Lxrα Deficiency Primes Retinal Degeneration, but Aging Drives Disease Severity.

    The American journal of pathology·2026
    Same journal

    MYC is functionally required in both normal and neoplastic Meibomian glands.

    The American journal of pathology·2026
    Same journal

    Fumaric Acid Esters as Modulators of Ocular Inflammation and Angiogenesis.

    The American journal of pathology·2026
    Same journal

    Krüppel-like factor 5 inhibition rescues cavernous nerve-injured erectile dysfunction by preventing phenotypic switch and mitochondrial dysfunction-dependent apoptosis in corpus cavernosum smooth muscle cells.

    The American journal of pathology·2026
    Same journal

    APOE4 as a Modifier of Chemotherapy Response.

    The American journal of pathology·2026
    Same journal

    Spatial Pathobiology in the Omics Era: Transforming Modern Pathology.

    The American journal of pathology·2026
    See all related articles

    Uremic spleen cells show reduced graft-versus-host (GVH) reactivity due to increased suppressor cells. Removing these suppressor cells restores GVH activity in uremic spleen cells, indicating their crucial role in immune suppression.

    Area of Science:

    • Immunology
    • Nephrology

    Background:

    • Uremia, a condition of severe kidney dysfunction, can impact immune cell function.
    • Graft-versus-host (GVH) disease is a complication of allogeneic stem cell transplantation.

    Purpose of the Study:

    • To investigate the graft-versus-host (GVH) reactivity of spleen cells from uremic rats.
    • To identify the mechanisms underlying altered immune responses in uremia.

    Main Methods:

    • Popliteal lymph node assay in rats to measure GVH reactivity.
    • Comparison of spleen cells from uremic and control rats.
    • Fractionation of spleen cells by adherence to glass wool.

    Main Results:

    • Uremic spleen cells exhibited significantly weaker GVH reactivity compared to control cells.

    Related Experiment Videos

  • Uremic spleen cells suppressed the GVH reactivity of normal control cells.
  • Removal of glass wool-adherent cells from uremic spleen cells restored GVH reactivity and eliminated suppressor effects.

    • Conclusions:

    • Increased suppressor cell activity in the uremic spleen cell population is responsible for the decreased GVH reactivity observed in uremia.
    • Targeting these suppressor cells may offer a therapeutic strategy for immune dysregulation in uremia.